Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report)'s stock price dropped 13.6% during mid-day trading on Tuesday . The stock traded as low as $0.73 and last traded at $0.73. Approximately 135,983 shares were traded during trading, a decline of 17% from the average daily volume of 164,109 shares. The stock had previously closed at $0.85.
Analyst Ratings Changes
Separately, Zacks Research upgraded Ascend Wellness to a "strong sell" rating in a research report on Tuesday, August 12th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Ascend Wellness currently has a consensus rating of "Sell".
Check Out Our Latest Research Report on Ascend Wellness
Ascend Wellness Trading Down 13.6%
The stock's 50 day simple moving average is $0.49 and its 200 day simple moving average is $0.39. The firm has a market cap of $149.24 million, a PE ratio of -1.78 and a beta of 1.15. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47.
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.